(Q46211547)

20 December 2017

title

Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury (English)

1 reference

20 December 2017

1 reference

1 reference

Shizuka Koshinuma

1

1 reference

20 December 2017

Masami Miyamae

2

1 reference

20 December 2017

Kazuhiro Kaneda

3

1 reference

20 December 2017

Junichiro Kotani

4

1 reference

20 December 2017

Vincent M Figueredo

5

1 reference

20 December 2017

language of work or name

1 reference

11 October 2013

1 reference

20 December 2017

published in

Journal of Anesthesia

1 reference

20 December 2017

volume

28

1 reference

20 December 2017

page(s)

235-241

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

Apoptosis in myocardial ischemia-reperfusion.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-κB and upregulation of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Caspase-independent programmed cell death with necrotic morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

RIP kinases at the crossroads of cell death and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

A novel role for RIP1 kinase in mediating TNFα production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Identification of RIP1 kinase as a specific cellular target of necrostatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Necrostatin: a potentially novel cardioprotective agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Cardioprotective signaling to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1716-3

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24113863

12 December 2020

inferred from PubMed ID database lookup

Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24113863

12 December 2020

inferred from PubMed ID database lookup

Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24113863

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00540-013-1716-3

1 reference

20 December 2017

release_ze672hu2lva67hx3bxxjtxzm4y

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ze672hu2lva67hx3bxxjtxzm4y

24 November 2022

mapped directly with Wikidata item

PubMed ID

24113863

1 reference

20 December 2017